Maxillofacial Plastic and Reconstructive Surgery

Korean Association of Maxillofacial Plastic and Reconstructive Surgeons (대한악안면성형재건외과학회)
권호 표지

HIV Screening Using the $OraQuick^{(R)}$ $ADVANCE^{TM}$ Rapid HIV-1/2 Antibody Test (OraQuick Test) in Dentistry: A Literature Review

$OraQuick^{(R)}$ $ADVANCE^{TM}$ Rapid HIV-1/2 Antibody Test를 이용한 치과에서의 인간면역결핍바이러스 검사: 문헌고찰

  • Im, Jae-Hyung (Department of Oral and Maxillofacial Surgery, School of Dentistry, Chosun University) ;
  • Kim, Su-Gwan (Department of Oral and Maxillofacial Surgery, School of Dentistry, Chosun University) ;
  • Oh, Ji-Su (Department of Oral and Maxillofacial Surgery, School of Dentistry, Chosun University)
  • 임재형 (조선대학교 치의학전문대학원 구강악안면외과학교실) ;
  • 김수관 (조선대학교 치의학전문대학원 구강악안면외과학교실) ;
  • 오지수 (조선대학교 치의학전문대학원 구강악안면외과학교실)
  • Received : 2010.09.20
  • Accepted : 2010.03.08
  • Published : 2011.05.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The purpose of this study was to evaluate the use of OraQuick tests in previously reported articles. Methods: The literature was searched using Pubmed Medline with keywords, such as "OraQuick" or "rapid HIV test". Articles that included the specificity and sensitivity of this device were reviewed. Results: A total of 11 journal articles including 3 domestic articles were reviewed. The sensitivity of the OraQuick Test was reported to be 97.8 to 100% and its specificity was 98.8 to 100%. Conclusion: The results indicated that the simple OraQuick assay has proven to be accurate and it can be used to detect patients with HIV and to prevent the spread of HIV on test screens.

Keywords

References

  1. Choi SM, Lee JY, Oh HS, et al. Survey of HIV exposure and postexposure prophylaxis among health care workers in Korea. Korean J Nosocomial Infect Control 2002;7:65-74.
  2. Choe KW. Epidemiology of HIV/AIDS: current status, trend and prospect. J Korean Med Assoc 2007;50:296-302. https://doi.org/10.5124/jkma.2007.50.4.296
  3. Kim JM, Song YG. Diagnosis and clinical manifestations of HIV/AIDS. J Korean Med Assoc 2007;50:303-15. https://doi.org/10.5124/jkma.2007.50.4.303
  4. Chung DR, Woo JH. Current status and epidemiology of AIDS. J Korean Med Assoc 1997;40:1548-53.
  5. Kim JM, Choi JY. HIV infection. HIV infection. Seoul: Koonja Publishing; 2007. p. 331-44.
  6. Hwang SH, Oh HB, Kim HS, Lee EY. Evaluation of HBsAg, HCV and HIV Ag-Ab assays using Bio-Radelite microplate analyzer. Korean J Lab Med 2006;26:436-41. https://doi.org/10.3343/kjlm.2006.26.6.436
  7. Kang HJ, Yoo KH, Kim HS, Cho HC. Evaluation of abbott fourth generation HIV antigen and antibody assays. Korean J Lab Med 2006;26:39-44. https://doi.org/10.3343/kjlm.2006.26.1.39
  8. Yeom JS, Ryu SH, Kang HJ, Park JW. Evaluation of new third generation LG Anti-HIV 1/2 plus ELISA Kit. Korean J Blood Transfus 2003;14:153-9.
  9. Cha YJ, Kwon SY, Kim TY, et al. Annual report on external quality assessment in immunoserology in Korea (2007). J Lab Med Qual Assur 2008;30:49-74.
  10. Lee EJ, Kim TH, Kim SH, et al. Rapid Diagnosis of human immunodeficiency virus infection using OraQuick Advance$^{\circledR}$ Rapid HIV-1/2 Antibody Test. Infect Chemother 2009;41:90-4. https://doi.org/10.3947/ic.2009.41.2.90
  11. Branson BM. FDA approves OraQuick for use in saliva. On March 25, the FDA approved the first rapid test for HIV in oral fluids. AIDS Clin Care 2004;16:39.
  12. Centers for Disease Control and Prevention (CDC). Approval of a new rapid test for HIV antibody. MMWR Morb Mortal Wkly Rep 2002;51:1051-2.
  13. Delaney KP, Branson BM, Uniyal A, et al. Performance of an oral fluid rapid HIV 1/2 test: experience from four CDC studies. AIDS 2006;20:1655-60. https://doi.org/10.1097/01.aids.0000238412.75324.82
  14. Wesolowski LG, MacKellar DA, Facente SN, et al. Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing. AIDS 2006;20:1661-6. https://doi.org/10.1097/01.aids.0000238413.13442.ed
  15. Branson BM. Rapid tests for HIV antibody. AIDS Rev 2000;2:76-83.
  16. Lim HS. Changing patterns of communicable diseases in Korea. Korean J Prev Med 2005;38:117-24.
  17. Branson B, Uniyal A, Fridlund C, Granade T, Kerndt P; Conference on Retroviruses and Opportunistic Infections. Performance of Newer Rapid Tests for HIV Antibody with Whole Blood and Plasma. 9th Conf Retrovir Oppor Infect Feb 24 28 2002 Wash State Conv Trade Cent Seattle Wash Conf Retrovir Oppor Infect 9th 2002 Seattle Wash. 2002 Feb 24-28; 9: abstract no. 599-T.
  18. O'Connell RJ, Merritt TM, Malia JA, et al. Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy. J Clin Microbiol 2003;41:2153-5. https://doi.org/10.1128/JCM.41.5.2153-2155.2003
  19. Reynolds SJ, Ndongala LM, Luo CC, et al. Evaluation of a rapid test for the detection of antibodies to hum an immunodeficiency virus type 1 and 2 in the setting of multiple transmitted viral subtypes. Int J STD AIDS 2002;13:171-3. https://doi.org/10.1258/0956462021924857
  20. Bhore AV, Sastry J, Patke D, et al. Sensitivity and specificity of rapid HIV testing of pregnant women in India. Int J STD AIDS 2003;14:37-41. https://doi.org/10.1258/095646203321043246
  21. Walensky RP, Arbelaez C, Reichmann WM, et al. Revising expectations from rapid HIV tests in the emergency department. Ann Intern Med 2008;149:153-60. https://doi.org/10.7326/0003-4819-149-3-200808050-00003
  22. Holguin A, Gutierrez M, Portocarrero N, Rivas P, Baquero M. Performance of OraQuick Advance Rapid HIV-1/2 Antibody Test for detection of antibodies in oral fluid and serum/plasma in HIV-1+ subjects carrying different HIV-1 subtypes and recombinant variants. J Clin Virol 2009;45:150-2. https://doi.org/10.1016/j.jcv.2009.04.002
  23. Choi TY, SeoYI, Kim TH, Shin JW, Park R. Evaluation of OraQuick Advance Rapid HIV-1/2 Antibody Test as a Screening Test for HIV Infection. Korean J Clin Microbiol 2009;12:116-21. https://doi.org/10.5145/KJCM.2009.12.3.116
  24. Pascoe SJS, Langhaug LF, Mudzori J, Burke E, Hayes R, Cowan FM. Field evaluation of diagnostic accuracy of an oral fluid rapid test for HIV, tested at point-of-service sites in rural Zimbabwe. AIDS Patient Care and STDs 2009;23:571-6. https://doi.org/10.1089/apc.2008.0225
  25. Piwowar-Manning EM, Tustin NB, Sikateyo P, et al. Validation of rapid HIV antibody tests in 5 African countries. J Int Assoc Physicians AIDS Care (Chic) 2010;9:170-2. https://doi.org/10.1177/1545109710368151
  26. Brown J, Magnus M, Czarnogorski M, Lee V. Another look at emergency department HIV screening in practice: no need to revise expectations. AIDS Res Ther 2010;7:1-6. https://doi.org/10.1186/1742-6405-7-1
  27. Park JC, Kim YT, Jung IH, et al. Attitudes about rapid Oral HIV screening test in dental clinics. J Korean Dent Associ 2009;47:211-6.
  28. Freeman A, Sattin R, Miller K, Dias J, Wilde J. Acceptance of rapid HIV screening in a southestern emergency department. Acad Emerg Med 2009;16:1156-63. https://doi.org/10.1111/j.1553-2712.2009.00508.x
  29. Central Statistical Office (CSO) (Zimbabwe), Macro International Inc. (2007) Zimbabwe Demographic and Health Survey 2005-06. Calverton, Maryland, USA: CSO and Macro International Inc.
  30. Jafa K, Patel P, Mackellar DA, et al. Investigation of false positive results with an oral fluid rapid HIV-1/2 antibody test. PLoS ONE 2007;2:185. https://doi.org/10.1371/journal.pone.0000185
  31. Centers for Disease Control and Prevention (CDC). False-positive oral fluid rapid tests. NewYork city, 2005-2008. MMWRMorb Mortal Wkly Rep 2008;57:660-5.
  32. Brown J, Shesser R, Simon G, et al. Routine HIV screening in the emergency department using the new US Centers for Disease Control and Prevention Guidelines: results froma high-prevalence area. J Acquir Immune Defic Syndr 2007;46:395-401. https://doi.org/10.1097/QAI.0b013e3181582d82
  33. Pai NP, Tulsky JP, Cohan D, Colford JM Jr, Reingold AL. Rapid point-of-care HIV testing in pregnant women: a systemic review and meta-analysis. Trop Med Int Health 2007;12:162-73. https://doi.org/10.1111/j.1365-3156.2006.01812.x
  34. Kshatriya R, Cachafeiro AA, Kerr RJ, Nelson JA, Fiscus SA. Comparison of two rapid human immunodeficiency virus (HIV) assays, determine HIV-1/2 and OraQuick Advance Rapid HIV-1/2, for detection of recent HIV seroconversion. J Clin Microbiol 2008;46:3482-3. https://doi.org/10.1128/JCM.00665-08
  35. Stekler J, Wood RW, Swenson PD, Golden M. Negative rapid HIV antibody testing during early HIV infection. Ann Intern Med 2007;147:147-8.
  36. Brown P, Merline JR, Levine D, Minces LR. Repeatedly false-negative rapid HIV-test results in a patient with undiagnosed advanced AIDS. Ann Intern Med 2008;149:71-2. https://doi.org/10.7326/0003-4819-149-1-200807010-00028
  37. Granade TC, Parekh BS, Phillips SK, McDougal JS. Performance of the OraQuick$^{\circledR}$ and Hema-Strip$^{\circledR}$ rapid HIV antibody detection assays by non-laboratorians. J Clin Virol 2004;30:229-32. https://doi.org/10.1016/j.jcv.2003.12.006
  38. Donovan BJ, Rublein JC, Leone PA, Pilcher CD. HIV infection: point-of-care testing. Ann Pharm acother 2004;38:670-6. https://doi.org/10.1345/aph.1D314
  39. Kim TY, Suh GJ, Kwak YH. Clinical features of emergency department visits by patients infected with human immunodeficiency virus and need for infection control. J Korean Soc Emerg Med 2005;16:458-66.
  40. Woo JH, Kang JM. The epidemiological characteristics of Korean people with HIV/AIDS. Korean J Med 2001;61:347-9.
  41. Seo DW, Lim KS, Lee JH, Youn JC, Kim W. Analysis of undiagnosed HIV-positive patients in the emergency room. J Korean Soc Emerg Med 2003;14:258-63.
  42. Walensky RP, Paltiel AD, Losina E, et al. The survival benefits of AIDS treatment in the United States. J Infect Dis 2006;194:11-9. https://doi.org/10.1086/505147